Jorge A. Goldstein, Ph.D. is a founder of the firm and a director in Sterne Kessler’s Biotechnology/Chemical Practice Group. Considered by his peers and clients to be one of the country’s pioneers in biotechnology patent law, in 2017, Jorge was inducted into LMG Life Sciences Hall of Fame and he was named as a finalist in their "Patent Strategy and Management Attorney of the Year- District of Columbia" category. He wrote the book U.S. Biotechnology Patent Law published in 2016, with a second edition including updates to case law published 2017. The books guide readers to understanding case law dealing with patents in biotechnology. He has almost forty years’ experience in the preparation and prosecution of patent applications before the U.S. and foreign patent offices in scientific areas such as genomics, molecular and cell biology, recombinant DNA technology, immunology, transgenics, therapeutic methods, stem cells, pharmaceuticals and more recently, BioFETs (biological field effect transistors).
In addition, Jorge chairs the firm's IP and Human Rights Pro Bono Practice, which was recognized as the winner of the 2015 Financial Times' Most Innovative North American Lawyers award in the "Innovation in a Social Responsibility Project" category. He has handled multiple and varied interferences over many years, including successful appeals to the Court of Appeals for the Federal Circuit. He has also been involved in inter partes reviews at the USPTO, as well as European oppositions, and arbitrations in District Court and in Appellate litigation both as counsel and expert witness, and in counseling clients on intellectual property strategy, trade secrets, licensing, research contracts, university-industry relations, federal licensing, due diligence, acquisitions and employment agreements. He was lead counsel in the 1988 appellate case of In re Wands et al. 8 USPQ2d 1400 (Fed. Cir.), a pivotal decision on biotechnology enablement requirements.
Jorge has been named Visiting Professor of Law by the Universidad Austral in Buenos Aires, Argentina, where he annually teaches biotech patent law in the only WIPO-certified regional master's IP program in Latin America.
Jorge received his J.D. from The George Washington University Law School with high honors, and his Ph.D. in chemistry from Harvard University. He earned his B.S. in chemistry from Rensselaer Polytechnic Institute.
Jorge's achievements include:
- LMG Life Sciences, "Hall of Fame Inductee" (2017)
- LMG Life Sciences, "Finalist: Patent Strategy and Management Attorney of the Year - District of Columbia category" (2017)
- Leaders League, "Innovation Technology & IP Rankings - Highly Recommended, Life Sciences" (2017)
- National Law Journal, "IP Trailblazer and Pioneer" (2016)
- Financial Times, "Most Innovative Lawyers in North America" (2015)
- Chambers USA, "Leading Lawyer in IP" (2017-2006)
- Chambers USA, "Leading Lawyer in the Life Sciences" (2017-2007)
- Who's Who Legal, "Patents & Life Sciences" (2017-2015; 2011)
- The Best Lawyers in America, "Washington DC Biotechnology Law 'Lawyer of the Year'" (2018; 2013)
- The Best Lawyers in America, "Washington DC Patent Law 'Lawyer of the Year'" (2017)
- Certified Licensing Professional (2014)
- The Best Lawyers in America, "Best Lawyers" (2018-2008)
- LMG Life Sciences, "Life Sciences Star" (2016-2012)
- Super Lawyers, "Super Lawyers - Washington DC" (2017-2008)
- Judge for Annual Law Practice Magazine EDGE Awards 2008-2009
- Martindale AV Preeminent Peer Rating 5.0/5.0
- IAM Patent 1000, "Highly Recommended Lawyer - Patent Prosecution; Recommended Lawyer - Patent Transactions" (2017)
- IAM Patent 1000, "Highly Recommended Lawyer - Patent Prosecution and Transactions" (2016-2013)
- IAM 250, "Leading Life Science Lawyer" (2010)
- The Legal 500, "Key Figure in Interferences - U.S." (2008-2007)
- Martindale Hubble Peer-Review Rating: AV
- Order of the Coif, George Washington University Law School, 1982
- Excellence in Teaching of Chemistry, Harvard University, 1972, 1974
- Class of 1902 Research Prize, Rensselaer Polytechnic Institute, 1971
- American Association for the Advancement of Science
- American Chemical Society
- American Intellectual Property Law Association Biotechnology Committee
- Biotechnology Industry Association